Stock comparison
ELI LILLY & Co is 439.4x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($1.059 T vs $2.41 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 439.4x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($1.059 T vs $2.41 B).
Market value leader
LLY
ELI LILLY & Co is 439.4x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($1.059 T vs $2.41 B).
Revenue leader
LLY
HRMY: $868.45M vs LLY: $65.18B.
Profit leader
LLY
HRMY: $158.69M vs LLY: $20.64B.
Margin leader
LLY
HRMY: 18.3% vs LLY: 31.7% net margin.
| Metric | HRMY | LLY |
|---|---|---|
| Market cap | $2.41 B | $1.059 T |
| US-listed rank | #1997 | #11 |
| Revenue (latest FY) | $868.45M | $65.18B |
| Net income (latest FY) | $158.69M | $20.64B |
| Net margin | 18.3% | 31.7% |
| P/E (trailing FY) | 15.2x | 51.3x |
| SEC filings | 434 | 995 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 439.4x more valuable than Harmony Biosciences Holdings, Inc. by market capitalization ($1.059 T vs $2.41 B).
In their latest fiscal years, Harmony Biosciences Holdings, Inc. reported $868.45M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Harmony Biosciences Holdings, Inc. and ELI LILLY & Co, or browse the full rankings.